Gene Cell Nano
GeneCellNano Flagship develops new biological drugs, so-called ATMP products, biomarkers and diagnostics for diseases with unmet clinical need. New treatments are developed for cardiovascular diseases and age-related macular degeneration, as well as for brain, ovarian and bladder cancer.
News
- Finnish COVID vaccine advances to clinical trial
- New EIC-funded NutriEV project studies nutrient-enriched extracellular vesicles
- Save the date for the Fourth Annual Meeting!
- Significant funding from Business Finland for retinopathy treatment research
- FinVector’s new gene therapy manufacturing hub opened in Kuopio
GeneCellNano is an interdisciplinary community of top experts specialized in biological Advanced Therapy Medicinal Products (ATMP) and nanotechniques linked with their management.
